Expression of human immunodeficiency virus type 1 gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: High- level production of virus-like particles containing HIV envelope

Virology

Volumn 268, Issue 1, 2000, Pages 112-121

  Haglund, Karl ^a   Forman, John ^a   Kräusslich, Hans Georg ^b   Rose, John K ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; PROTEIN PRECURSOR; VIRUS ENVELOPE PROTEIN;

ARTICLE; CONTROLLED STUDY; GENE INSERTION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECOMBINANT DNA TECHNOLOGY; VESICULAR STOMATITIS VIRUS; VIRUS GENE; VIRUS GENOME; VIRUS PARTICLE; VIRUS RECOMBINANT;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES; TRIXIS; VESICULAR STOMATITIS VIRUS;

EID: 0034090316     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.0120     Document Type: Article

References (45)

1. Boritz E., Gerlach J., Johnson J. E., Rose J. K. Replication-competent rhabdoviruses with human immunodeficiency virus type 1 coats and green fluorescent protein: entry by a pH-independent pathway. J. Virol. 73:1999;6937-6945.
2. Cosson P. Direct interaction between the envelope and matrix proteins of HIV-1. EMBO J. 15:1996;5783-5788.
3. Delchambre M., Gheysen D., Thines D., Thiriart C., Jacobs E., Verdin E., Horth M., Burny A., Bex F. The GAG precursor of simian immunodeficiency virus assembles into virus-like particles. EMBO J. 8:1989;2653-2660.
4. Dietzschold B., Ruppreccht C. E., Fu Z. F., Koprowski H. Rhabdoviruses. Knipe D. M., Fields B. N., Howley P. M. Field's Virology. 1996;1137-1159 Lippincott-Raven, Philadelphia.
5. Freed E. O., Orenstein J. M., Buckler-White A. J., Martin M. A. Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. J. Virol. 68:1994;5311-5320.
6. Freed E. O., Martin M. A. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J. Virol. 69:1995;1984-1989.
7. Freed E. O., Martin M. A. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J. Virol. 70:1996;341-351.
8. Fuerst T. R., Niles E. G., Studier F. W., Moss B. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA. 83:1986;8122-8126.
9. Gelderblom H. R. Assembly and morphology of HIV: potential effect of structure on viral function. AIDS. 5:1991;617-638.
10. Gheysen D., Jacobs E., de Foresta F., Thiriart C., Francotte M., Thines D., DeWilde M. Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell. 59:1989;103-112.
11. Gottlinger H. G., Sodroski J. G., Haseltine W. A. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 86:1989;5781-5785.
12. Haffar O., Garrigues J., Travis B., Moran P., Zarling J., Hu S.-L. Human immunodeficiency virus-like, nonreplicating, gag-env particles assemble in a recombinant vaccinia virus expression system. J. Virol. 64:1990;2653-2659.
13. Haffar O. K., Smithgall M. D., Moran P. A., Travis B. M., Zarling J. M., Hu S. L. HIV-specific humoral and cellular immunity in rabbits vaccinated with recombinant human immunodeficiency virus-like gag-env particles. Virology. 183:1991;487-495.
14. Haynes B. F., Pantaleo G., Fauci A. S. Toward an understanding of the correlates of protective immunity to HIV infection. Science. 271:1996;324-328.
15. Iverson L. E., Rose J. K. Localized attenuation and discontinuous synthesis during vesicular stomatitis virus transcription. Cell. 23:1981;477-484.
16. Jacks T., Power M. D., Asiarz F. R., Luciw P. A., Barr P. J., Varmus H. E. Characterisation of ribosomal frameshifting in HIV-1 gag-pol expression. Nature. 331:1988;280-283.
17. Johnson J. E., Schnell M. J., Buonocore L., Rose J. K. Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins. J.Virol. 71:1997;5065-5068.
18. Johnson J. E., Rodgers W., Rose J. K. A plasma membrane localization signal in the HIV-1 envelope cytoplasmic domain prevents localization at sites of vesicular stomatitis virus budding and incorporation into VSV virions. Virology. 251:1998;244-252.
19. Kahn J. S., Schnell M. J., Buonocore L., Rose J. K. Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion. Virology. 254:1999;81-91.
20. Karacostas V., Nagashima K., Gonda M. A., Moss B. Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector. Proc. Natl. Acad. Sci. USA. 86:1989;8964-8967.
21. Kräusslich H.-G., Ochsenbauer C., Traenckner A. M., Mergener K., Facke M., Gelderblom H. R., Bosch V. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase. Virology. 192:1993;605-617.
22. Kretzschmar E., Buonocore L., Schnell M. J., Rose J. K. High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses. J. Virol. 71:1997;5982-5989.
23. Lawson N. D., Stillman E. A., Whitt M. A., Rose J. K. Recombinant vesicular stomatitis viruses from DNA. Proc. Natl. Acad. Sci. USA. 92:1995;4477-4481.
24. Mammano F., Kondo E., Sodroski J., Bukovsky A., Gottlinger H. G. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains. J. Virol. 69:1995;3824-3830.
25. Mergener K., Facke M., Welker R., Brinkmann V., Gelderblom H. R., Krausslich H. Analysis of HIV particle formation using transient expression of subviral constructs in mammalian cells. Virology. 186:1992;25-39.
26. Owens R. J., Rose J. K. Cytoplasmic domain requirement for incorporation of a foreign envelope protein into vesicular stomatitis virus. J. Virol. 67:1993;360-365.
27. Porter D. C., Melsen L. R., Compans R. W., Morrow C. D. Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 Gag. J. Virol. 70:1996;2643-2649.
28. Roberts A., Rose J. K. Recovery of negative-strand RNA viruses from plasmid DNAs: a positive approach revitalizes a negative field. Virology. 247:1998;1-6.
29. Roberts A., Kretzschmar E., Perkins A. S., Forman J., Price R., Buonocore L., Kawaoka Y., Rose J. K. Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge. J. Virol. 72:1998;4704-4711.
30. Roberts A., Buonocore L., Price R., Forman J., Rose J. K. Attenuated vesicular stomatitis viruses as vaccine vectors. J. Virol. 73:1999;3723-3732.
31. Royer M., Hong S.-S., Gay B., Cerutti M., Boulanger P. Expression and extracellular release of human immunodeficiency type 1 gag precursors by recombinant baculovirus-infected cells. J. Virol. 66:1992;3230-3235.
32. Sattentau Q. J., Moore J. P. Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer. J. Exp. Med. 182:1995;185-196.
33. Schnell M. J., Buonocore L., Kretzschmar E., Johnson E., Rose J. K. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Proc. Natl. Acad. Sci. USA. 93:1996a;11359-11365.
34. Schnell M. J., Buonocore L., Whitt M. A., Rose J. K. The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus. J. Virol. 70:1996b;2318-2323.
35. Schnell M. J., Johnson J. E., Buonocore L., Rose J. K. Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection. Cell. 90:1997;849-857.
36. Schnell M. J., Buonocore L., Boritz E., Ghosh H. P., Chernish R., Rose J. K. Requirement for a non-specific glycoprotein cytoplasmic domain sequence to drive efficient budding of vesicular stomatitis virus. EMBO J. 17:1998;1289-1296.
37. Smith A. J., Srinivasakumar N., Hammarskjold M. L., Rekosh D. Requirements for incorporation of Pr160gag-pol from human immunodeficiency virus type 1 into virus-like particles. J .Virol. 67:1993;2266-2275.
38. Vogt V. M. Proteolytic processing and particle maturation. Curr. Top. Microbiol. Immunol. 214:1996;95-131.
39. Wagner R. R., Rose J. K. Rhabdoviridae: the viruses and their replication. Fields B. N., Knipe D. M., Howley P. M. Fundamental Virology. 1996;561-576 Lippincott-Raven, Philadelphia.
40. Wagner R., Deml L., Schirmbeck R., Reimann J., Wolf H. Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development. Behring Inst. Mitt. 95:1994;23-34.
41. Wagner R., Deml L., Schirmbeck R., Niedrig M., Reimann J., Wolf H. Construction, expression, and immunogenicity of chimeric HIV-1 virus-like particles. Virology. 220:1996a;128-140.
42. Wagner R., Deml L., Teeuwsen V., Heeney J., Yiming S., Wolf H. A recombinant HIV-1 virus-like particle vaccine: from concepts to a field study. Antibiot. Chemother. 48:1996b;68-83.
43. Wang C. T., Lai H. Y., Li J. J. Analysis of minimal human immunodeficiency virus type 1 gag coding sequences capable of virus-like particle assembly and release. J. Virol. 72:1998;7950-7959.
44. Whelan S. P. J., Ball L. A., Barr J. N., Wertz G. T. W. Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. Proc. Natl. Acad. Sci. USA. 85:1995;9580-9584.
45. Zinkernagel R. M., Adler B., Holland J. J. Cell-mediated immunity to vesicular stomatitis virus infections in mice. Exp. Cell Biol. 46:1978;53-70.